Walter M. Stadler to Vascular Endothelial Growth Factor Receptor-3
This is a "connection" page, showing publications Walter M. Stadler has written about Vascular Endothelial Growth Factor Receptor-3.
Connection Strength
0.020
-
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol. 2008 Aug 01; 26(22):3743-8.
Score: 0.020
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.